Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature
-
Therdpong Tempark
,
Tawatchai Deekajorndech
Abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) is one of the severe cutaneous adverse drug reactions (SCARs) with high mortality rate and variable long term sequelae, especially in thyroid dysfunction and thyroiditis. In this article, we review clinical course, culprit drugs, onset of diagnosis, and type of thyroid dysfunction in DRESS patients. There were a total of 51 cases including 12 children (aged less than 18 years old) and 39 adults from our review. The most common thyroid dysfunction was Hashimoto’s thyroiditis (41/51=80.4%) including anti-thyroid antibody positive (29/51=56.9%), possible/compatible with Hashimoto’s thyroiditis (12/51=23.5%) both in the children (n=12) and adult (n=39), Graves’ disease/hyperthyroidism (7/51=13.7%) and non-specific hypothyroidism (3/51=5.9%), respectively. The most common culprit drugs and onset of thyroid dysfunction after DRESS diagnosis in children aged less than 18 years include antiepileptic drugs (phenytoin, phenobarbital, carbamazepine) (range 0–8 months, median 2 months) and sulfa groups (sulfasalazine, sulfamethoxazole, sulfonamide) (range 1–4 months, median 2 months). Data of prevalence, type, and clinical course of thyroid dysfunction from DRESS is important for clinicians to recognize for monitoring its sequelae and provide plans for treatment.
Acknowledgment
The authors would like to thank Ms. Sunattee Kessung for her assistance in editing and revising this manuscript.
-
Research funding: None declared.
-
Author contribution: All of the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. TT interpreted the data, conceived, designed and drafted the study, conducted the work and drafted and revised the article; VS conceived and designed the study, revised the article; TD, SC, SW revised the article.
-
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Jantararoungtong, T, Tempark, T, Koomdee, N, Medhasi, S, Sukasem, C. Genotyping HLA alleles to predict the development of severe cutaneous adverse drug reactions (SCARs): state-of-the-art. Expet Opin Drug Metabol Toxicol 2021;17:1049–64. https://doi.org/10.1080/17425255.2021.1946514.Search in Google Scholar
2. Bocquet, H, Bagot, M, Roujeau, JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996;15:250–7. https://doi.org/10.1016/s1085-5629(96)80038-1.Search in Google Scholar
3. Sukasem, C, Tempark, T. Pharmacogenomics: a new approach for preventing severe cutaneous adverse drug reactions. In: Pathak, Y, editor. Genomics-driven healthcare: trends in disease prevention and treatment. Singapore: Springer Nature; 2018:373–409 pp.10.1007/978-981-10-7506-3_18Search in Google Scholar
4. Kim, GY, Anderson, KR, Davis, DMR, Hand, JL, Tollefson, MM. Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: a systematic review of the literature. J Am Acad Dermatol 2020;83:1323–30. https://doi.org/10.1016/j.jaad.2020.03.081.Search in Google Scholar PubMed
5. Teo, RY, Tay, YK, Tan, CH, Ng, V, Oh, DC. Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis. Ann Acad Med Singapore 2006;35:833–6.10.47102/annals-acadmedsg.V35N11p833Search in Google Scholar
6. Ye, YM, Kim, JE, Kim, JH, Choi, GS, Park, HS. Propylthiouracil-induced DRESS syndrome confirmed by a positive patch test. Allergy 2010;65:407–9. https://doi.org/10.1111/j.1398-9995.2009.02183.x.Search in Google Scholar PubMed
7. Shaughnessy, KK, Bouchard, SM, Mohr, MR, Herre, JM, Salkey, KS. Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis. J Am Acad Dermatol 2010;62:315–8. https://doi.org/10.1016/j.jaad.2009.05.046.Search in Google Scholar PubMed
8. Tung, Y, Escutia, B, Blanes, M, Navarrro, M, Pujol, C. Sulfasalazine-induced hypersensitivity syndrome associated with human herpesvirus 6 reactivation and induction of antiphospholipid syndrome. Actas Dermosifiliogr 2011;102:537–40. https://doi.org/10.1016/j.adengl.2010.12.002.Search in Google Scholar
9. Mizumoto, K, Sumikawa, Y, Niihara, H, Morita, E. Case of carbamazepine-induced hypersensitivity syndrome associated with human leukocyte antigen-A*3101. J Dermatol 2012;39:791–2. https://doi.org/10.1111/j.1346-8138.2011.01421.x.Search in Google Scholar PubMed
10. Cookson, H, Creamer, D, Walsh, S. Thyroid dysfunction in drug reaction with eosinophilia and systemic symptoms (DRESS): an unusual manifestation of systemic drug hypersensitivity. Br J Dermatol 2013;168:1130–2. https://doi.org/10.1111/bjd.12169.Search in Google Scholar PubMed
11. Chen, YC, Chang, CY, Cho, YT, Chiu, HC, Chu, CY. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol 2013;68:459–65. https://doi.org/10.1016/j.jaad.2012.08.009.Search in Google Scholar PubMed
12. Ushigome, Y, Kano, Y, Ishida, T, Hirahara, K, Shiohara, T. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol 2013;68:721–8. https://doi.org/10.1016/j.jaad.2012.10.017.Search in Google Scholar PubMed
13. Descamps, V. Drug reaction with eosinophilia and systemic symptoms and thyroiditis: human herpesvirus-6, the possible common link. Br J Dermatol 2013;169:952. https://doi.org/10.1111/bjd.12456.Search in Google Scholar PubMed
14. Descamps, V, Ranger-Rogez, S. DRESS syndrome. Joint Bone Spine 2014;81:15–21. https://doi.org/10.1016/j.jbspin.2013.05.002.Search in Google Scholar PubMed
15. Minegaki, Y, Higashida, Y, Ogawa, M, Miyachi, Y, Fujii, H, Kabashima, K. Drug-induced hypersensitivity syndrome complicated with concurrent fulminant type 1 diabetes mellitus and Hashimoto’s thyroiditis. Int J Dermatol 2013;52:355–7. https://doi.org/10.1111/j.1365-4632.2011.05213.x.Search in Google Scholar PubMed
16. Ito, K, Akita, Y, Ishida, N, Kasugai, C, Tamada, Y, Watanabe, D. Painless thyroiditis in drug-induced hypersensitivity syndrome with prolonged reactivation of herpesviruses. Int J Dermatol 2013;52:475–7. https://doi.org/10.1111/j.1365-4632.2011.05240.x.Search in Google Scholar PubMed
17. Singer, EM, Wanat, KA, Rosenbach, MA. A case of recalcitrant DRESS syndrome with multiple autoimmune sequelae treated with intravenous immunoglobulins. JAMA Dermatol 2013;149:494–5. https://doi.org/10.1001/jamadermatol.2013.1949.Search in Google Scholar PubMed
18. Kano, Y, Tohyama, M, Aihara, M, Matsukura, S, Watanabe, H, Sueki, H, et al.. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J Dermatol 2015;42:276–82. https://doi.org/10.1111/1346-8138.12770.Search in Google Scholar PubMed
19. Sato, M, Mizuno, Y, Matsuyama, K, Shu, E, Kanoh, H, Suwa, T, et al.. Drug-induced hypersensitivity syndrome followed by subacute thyroiditis. Case Rep Dermatol 2015;7:161–5. https://doi.org/10.1159/000437251.Search in Google Scholar PubMed PubMed Central
20. Marchese, M, Leinung, M, Shawa, H. Drug-induced hypersensitivity reaction: a case of simultaneous thyroiditis and fulminant type 1 diabetes. Avicenna J Med 2017;7:67–70. https://doi.org/10.4103/ajm.AJM_124_16.Search in Google Scholar PubMed PubMed Central
21. Matta, JM, Flores, SM, Cherit, JD. Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico. An Bras Dermatol 2017;92:30–3. https://doi.org/10.1590/abd1806-4841.20175190.Search in Google Scholar PubMed PubMed Central
22. Deng, M, Wu, H, Yu, M, Tian, Y, Li, Y, Xiao, X. Co-occurrence of multiple endocrine abnormalities induced by the DIHS/DRESS. Internet J Endocrinol 2019;2019:7959615. https://doi.org/10.1155/2019/7959615.Search in Google Scholar PubMed PubMed Central
23. Chen, X, Cai, Y, Ge, X. Allopurinol-induced hypersensitivity syndrome followed by painless thyroiditis in a patient with asymptomatic hyperuricemia. Arch Med Sci 2020;16:1254–6. https://doi.org/10.5114/aoms.2020.97971.Search in Google Scholar PubMed PubMed Central
24. Truong, K, Kelly, S, Bayly, A, Smith, A. Successful mepolizumab treatment for DRESS-induced refractory eosinophilic myocarditis and concurrent thyroiditis. BMJ Case Rep 2021;14:e242240. https://doi.org/10.1136/bcr-2021-242240.Search in Google Scholar PubMed PubMed Central
25. Sandhu, S, Neema, S, Vashisht, D, Venugopal, R, Sengupta, P, Radhakrishnan, S. Drug reaction with eosinophilia and systemic symptoms: a single center descriptive observational study. Dermatol Ther 2021;34:e14670. https://doi.org/10.1111/dth.14670.Search in Google Scholar PubMed
26. Shiiya, C, Ouchi, T, Funakoshi, T, Amagai, M, Takahashi, H. Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases. J Dermatol 2021;48:e45–6. https://doi.org/10.1111/1346-8138.15639.Search in Google Scholar PubMed
27. Gupta, A, Eggo, MC, Uetrecht, JP, Cribb, AE, Daneman, D, Rieder, MJ, et al.. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther 1992;51:56–67. https://doi.org/10.1038/clpt.1992.8.Search in Google Scholar PubMed
28. Brown, RJ, Rother, KI, Artman, H, Mercurio, MG, Wang, R, Looney, RJ, et al.. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 2009;145:63–6. https://doi.org/10.1001/archdermatol.2008.521.Search in Google Scholar PubMed PubMed Central
29. Shastry, V, Betkerur, J. Hypothyroidism as a late manifestation of drug hypersensitivity syndrome. Indian J Dermatol 2010;55:405–6. https://doi.org/10.4103/0019-5154.74574.Search in Google Scholar PubMed PubMed Central
30. Coughlin, CC, Jen, MV, Boos, MD. Drug hypersensitivity syndrome with prolonged course complicated by parvovirus infection. Pediatr Dermatol 2016;33:e364–5. https://doi.org/10.1111/pde.13007.Search in Google Scholar PubMed
31. Morita, C, Yanase, T, Shiohara, T, Aoyama, Y. Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome. BMJ Case Rep 2018. https://doi.org/10.1136/bcr-2018-225528.Search in Google Scholar PubMed PubMed Central
32. Oberlin, KE, Rahnama-Moghadam, S, Alomari, AK, Haggstrom, AN. Drug reaction with eosinophilia and systemic symptoms: pediatric case series and literature review. Pediatr Dermatol 2019;36:887–92. https://doi.org/10.1111/pde.13949.Search in Google Scholar
33. Onuma, H, Tohyama, M, Imagawa, A, Hanafusa, T, Kobayashi, T, Kano, Y, et al.. Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research; Japanese Dermatological association. High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome. J Clin Endocrinol Metab 2012;97:E2277–81. https://doi.org/10.1210/jc.2012-2054.Search in Google Scholar
34. Park, BK, Coleman, JW, Kitteringham, NR. Drug disposition and drug hypersensitivity. Biochem Pharmacol 1987;36:581–90. https://doi.org/10.1016/0006-2952(87)90706-4.Search in Google Scholar
35. Cribb, AE, Nuss, CE, Alberts, DW, Lamphere, DB, Grant, DM, Grossman, SJ, et al.. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Chem Res Toxicol 1996;9:500–7. https://doi.org/10.1021/tx950167j.Search in Google Scholar PubMed
36. Kubow, S, Wells, PG. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase. Mol Pharmacol 1989;35:504–11.Search in Google Scholar
37. Picard, D, Janela, B, Descamps, V, D’Incan, M, Courville, P, Jacquot, S, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010;2:46ra62. https://doi.org/10.1126/scitranslmed.3001116.Search in Google Scholar PubMed
38. Tohyama, M, Hashimoto, K, Yasukawa, M, Kimura, H, Horikawa, T, Nakajima, K, et al.. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 2007;157:934–40. https://doi.org/10.1111/j.1365-2133.2007.08167.x.Search in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review Article
- Impact of Obesity on Bone Metabolism in Children
- Mini Review
- Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature
- Original Articles
- Moderating effect of bone maturation on the relationship between body fat and insulin resistance
- Prevalence of nephropathy in Indian children and youth with type 1 diabetes mellitus
- Initial neutrophil/lymphocyte and lymphocyte/monocyte ratios can predict future insulin need in newly diagnosed type 1 diabetes mellitus
- Subcutaneous adipose tissue is a positive predictor for bone mineral density in prepubertal children with Prader–Willi syndrome independent of lean mass
- The attitudes, experiences, and self-competencies of pediatric endocrinology fellows and attending physicians regarding diabetes technology: the Turkey experience
- Adiposity measures in screening for metabolic syndrome among Chinese children and adolescents
- Increased anxiety symptoms in pediatric type 1 diabetes during the acute phase of COVID-19 lockdown
- Pediatric adrenal insufficiency: thirty years experience at a Portuguese hospital
- Spectrum of PAH gene mutations and genotype–phenotype correlation in patients with phenylalanine hydroxylase deficiency from Turkey
- Serum spexin levels are not associated with size at birth but are associated with metabolic syndrome components in prepubertal children born at term
- Familial early-onset obesity in Turkish children: variants and polymorphisms in the melanocortin-4 receptor (MC4R) gene
- An update of the mutation spectrum of phenylalanine hydroxylase (PAH) gene in the population of Turkey
- Primary hypertriglyceridemia induced pancreatitis in a cohort of Pakistani children
- Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus
- Case Reports
- Diagnostic value of plasma lysosphingolipids levels in a Niemann–Pick disease type C patient with transient neonatal cholestasis
- A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity
- Homozygous missense variant of PTH (c.166C>T, p.(Arg56Cys)) as the cause of familial isolated hypoparathyroidism in a three-year-old child
- Long-term follow-up of transient neonatal diabetes mellitus due to a novel homozygous c.7734C>T (p.R228C) mutation in ZFP57 gene: relapse at prepubertal age
Articles in the same Issue
- Frontmatter
- Review Article
- Impact of Obesity on Bone Metabolism in Children
- Mini Review
- Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature
- Original Articles
- Moderating effect of bone maturation on the relationship between body fat and insulin resistance
- Prevalence of nephropathy in Indian children and youth with type 1 diabetes mellitus
- Initial neutrophil/lymphocyte and lymphocyte/monocyte ratios can predict future insulin need in newly diagnosed type 1 diabetes mellitus
- Subcutaneous adipose tissue is a positive predictor for bone mineral density in prepubertal children with Prader–Willi syndrome independent of lean mass
- The attitudes, experiences, and self-competencies of pediatric endocrinology fellows and attending physicians regarding diabetes technology: the Turkey experience
- Adiposity measures in screening for metabolic syndrome among Chinese children and adolescents
- Increased anxiety symptoms in pediatric type 1 diabetes during the acute phase of COVID-19 lockdown
- Pediatric adrenal insufficiency: thirty years experience at a Portuguese hospital
- Spectrum of PAH gene mutations and genotype–phenotype correlation in patients with phenylalanine hydroxylase deficiency from Turkey
- Serum spexin levels are not associated with size at birth but are associated with metabolic syndrome components in prepubertal children born at term
- Familial early-onset obesity in Turkish children: variants and polymorphisms in the melanocortin-4 receptor (MC4R) gene
- An update of the mutation spectrum of phenylalanine hydroxylase (PAH) gene in the population of Turkey
- Primary hypertriglyceridemia induced pancreatitis in a cohort of Pakistani children
- Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus
- Case Reports
- Diagnostic value of plasma lysosphingolipids levels in a Niemann–Pick disease type C patient with transient neonatal cholestasis
- A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity
- Homozygous missense variant of PTH (c.166C>T, p.(Arg56Cys)) as the cause of familial isolated hypoparathyroidism in a three-year-old child
- Long-term follow-up of transient neonatal diabetes mellitus due to a novel homozygous c.7734C>T (p.R228C) mutation in ZFP57 gene: relapse at prepubertal age
